Category: News

dea schedule III

DEA Opens New Schedule III Registration Portal for Medical Cannabis Businesses

The DEA has opened a new Schedule III registration process for state-licensed medical cannabis businesses, bringing manufacturers, distributors and labs into a federal controlled-substances framework. The shift also carries major tax implications, including relief from Section 280E for qualifying operators.

90% of Americans Want Legal Weed. Lawmakers in Both Parties Keep Punishing Them for It.

NORML’s Paul Armentano on the two-front war against cannabis consumers: Republican lawmakers overturning or attacking voter-approved legalization in South Dakota, Nebraska, Ohio, Texas and Idaho, while Democratic lawmakers in Michigan, Maryland and Minnesota hike taxes high enough to push consumers back into the illicit market.

The FDA Wants to Talk Psychedelic Therapy. The Movement Has Bigger Questions.

The FDA’s written comment period on therapeutic psychedelics closes October 5, and the notice is narrower than most people calling for comments seem to realize. The National Psychedelics Association is backing an ADA lawsuit over Oregon’s centers-only rule. Port Townsend is pushing grow-your-own, and says many of its local mushroom growers are retirees. San Francisco is training a professional class. And a Brooklyn Buddhist group is worried legalization will make the experience too easy.

jamaica cannabis growers

Jamaica’s Cannabis Reform Opens a New Path for Small Growers

Jamaica has introduced two new special permits designed to help traditional growers and small farmers enter its regulated cannabis industry despite the financial, technical and administrative barriers that have historically kept them out. The reforms create transitional and community-based pathways into the legal market while extending cultivation licenses and simplifying some requirements. Jamaica is one of the countries with the

Read More »
cannabis abstinence

Cannabis Withdrawal Treatment: Experimental Drug Shows Promise in Small Trial

An experimental drug combining nabilone and gabapentin reduced the severity and bothersomeness of cannabis withdrawal symptoms in a small randomized, placebo-controlled trial involving adults with moderate-to-severe cannabis use disorder. The results offer an early signal of potential benefit, but with only 14 participants, a short study period and financial ties to the drug’s developer, much larger trials will be needed

Read More »
thailand adult use

Thailand Advances Medical-Only Cannabis Bill as Adult-Use Era Fades

Thailand is moving closer to putting its medical-only cannabis model into national law, with a new bill that would require licenses across the supply chain, restrict sales to medical and research purposes, and prohibit advertising and promotion. Thousands of existing dispensaries could continue operating until their current licenses expire, but many would then need to transition into healthcare facilities and

Read More »
ecuador hemp

Ecuador’s Hemp Market Is Growing Fast—and It’s Not Just About Cultivation

Ecuador’s hemp sector is projected to approach or surpass $20 million in 2026 as companies move beyond raw biomass into chocolates, cosmetics, supplements, veterinary products and other finished goods. With more than 700 companies operating across the supply chain, the industry is now looking to capture more value domestically while expanding finished-product exports into international markets. When people talk about

Read More »

The FDA Wants to Talk Psychedelic Therapy. The Movement Has Bigger Questions.

The FDA’s written comment period on therapeutic psychedelics closes October 5, and the notice is narrower than most people calling for comments seem to realize. The National Psychedelics Association is backing an ADA lawsuit over Oregon’s centers-only rule. Port Townsend is pushing grow-your-own, and says many of its local mushroom growers are retirees. San Francisco is training a professional class. And a Brooklyn Buddhist group is worried legalization will make the experience too easy.

Read More »

Subscribe to High Times

Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!